Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children

References

• Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2006;117:572–576.
   Google Scholar
• Chen J, Stahl A, Hellstrom A, Smith LE. Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr 2011;23(2):173–178.
   PubMed Web of Science ®Google Scholar
• Early treatment for retinopathy of prematurity cooperative group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684–1694.
   Google Scholar
• Axer-Siegel R, Maharshak I, Snir M, Friling R, Ehrlich R, Sherf I, et al. Diode laser treatment of retinopathy of prematurity: anatomic al and refractive outcomes. Retina 2008;28:839–846.
   PubMed Web of Science ®Google Scholar
• McLoone E, O’Keefe M, McLoone S, Lanigan B. Long term functional and structural outcomes of laser therapy for retinopathy of prematurity. Br J Ophthalmol 2006;90:754–759.
   PubMed Web of Science ®Google Scholar
• Hwang CK, Hubbard GB, Hutchinson AK, Lambert SR. Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis. Ophthalmology 2015;122(5):1008–1015.
   PubMed Web of Science ®Google Scholar
• Mintz-Hittner HA, Kuffel RR. Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 2008;28(6):831–838.
   PubMed Web of Science ®Google Scholar
• Castellanos MA, Schwartz S, García-Aguirre G, Quiroz-Mercado H. Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity. Br J Ophthalmol 2013;97(7):816–819.
   PubMed Web of Science ®Google Scholar
• Chen SN, Lian I, Hwang YC, Chen YH, Chang YC, Lee KH, et al. Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between ranibizumab and bevacizumab. Retina 2015;35(4):667–674.
   PubMed Web of Science ®Google Scholar
• Quiroz-Mercado H, Martinez-Castellanos MA, Hernandez- Rojas ML, et al. Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 2008;28(3 Suppl):19–25.
   Web of Science ®Google Scholar
• Harder BC, Von Baltz S, Jonas JB, Schlichtenbrede FC. Intravitreal bevacizumab for retinopathy of prematurity. J Ocul Pharmacol Ther 2011;27:623–627.
   PubMed Web of Science ®Google Scholar
• Kusaka S, Shima C, Wada K, Arahori H, Shimojyo H, Sato T, et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 2008;92:1450–1455.
   PubMed Web of Science ®Google Scholar
• Travassos A, Teixeira S, Ferreira P, Regadas I, Travassos AS, Esperancinha FE, et al. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging 2007;38:233–237.
   PubMedGoogle Scholar
• Dorta P, Kychenthal A. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin). Retina 2010;30(4 Suppl):24–31.
   Google Scholar
• Wu WC, Kuo HK, Yeh PT, Yang CM, Lai CC, Chen SN. An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in Taiwan. Am J Ophthalmol 2013;155:150–158e1.
   PubMed Web of Science ®Google Scholar
• Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011;364:603–615.
   PubMed Web of Science ®Google Scholar
• Harder BC, Schlichtenbrede FC, Von Baltz S, Jendritza W, Jendritza B, Jonas JB. Intravitreal bevacizumab for retinopathy of prematurity: refractive error results. Am J Ophthalmol 2013;155:1119–1124.
   PubMed Web of Science ®Google Scholar
• Kuo HK, Sun IT, Chung MY, Chen YH. Refractive error in patients with retinopathy of prematurity after laser photocoagulation or bevacizumab monotherapy. Ophthalmologica 2015;234(4):211–217.
   PubMed Web of Science ®Google Scholar
• Geloneck MM, Chuang AZ, Clark WL, Hunt MG, Norman AA, Packwood EA, et al., BEAT-ROP Cooperative Group. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA Ophthalmol 2014;132(11):1327–1333.
   Google Scholar
• Menke MN, Framme C, Nelle M, Berger MR, Sturm V, Wolf S. Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease. BMC Ophthalmol 2015;15:20.
   PubMed Web of Science ®Google Scholar
• Yi Z, Su Y, Zhou Y, Zheng H, Ye M, Xu Y, et al. Effects of Intravitreal Ranibizumab in the treatment of retinopathy of prematurity in Chinese infants. Curr Eye Res 2015;18:1–6.
   Google Scholar
• Baumal CR, Goldberg RA, Fein JG. Primary intravitreal ranibizumab for high-risk retinopathy of prematurity. Ophthalmic Surg Lasers Imaging Retina 2015;46(4):432–438.
   PubMed Web of Science ®Google Scholar
• Wong RK, Hubschman S, Tsui I. Reactivation of retinopathy of prematurity after ranibizumab treatment. Retina 2015;35(4):675–680.
   PubMed Web of Science ®Google Scholar
• Castellanos MA, Schwartz S, García-Aguirre G, Quiroz-Mercado H. Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity. Br J Ophthalmol 2013;97(7):816–819.
   PubMed Web of Science ®Google Scholar
• Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 2007;114:855–859.
   PubMed Web of Science ®Google Scholar
• Bakri SJ, Snyder MR, Reid JM, Pulido JS, Ezzat MK, Singh RJ. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology 2007;114:2179–2182.
   PubMed Web of Science ®Google Scholar
• Kabatas EU, Ozer PA, Kurtul BE, Kabatas N, Beken S, Zencioroglu A, et al. Systemic steroid for exudative retinal detachment following laser photocoagulation for retinopathy of prematurity. Am J Med Sci Med 2015;3(5):67–69.
   Google Scholar
• Moshfeghi DM, Silva RA, Berrocal AM. Exudative retinal detachment following photocoagulation in older premature infants for retinopathy of prematurity: description and management. Retina 2014;34(1):83–86.
   PubMed Web of Science ®Google Scholar